A University of Texas Dallas www.utdalla.edu led initiative is identifying potentially marketable biomedical technologies developed within University of Texas System institutions and move them more efficiently from the laboratory bench to the bedside.
The UT Office of Technology Commercialization www.utsystem.edu/offices/technology-commercialization has launched the Entrepreneurship Network that has a $172,500 agreement with UT Dallas to establish a Medical Technology Lean Startup Course with the purpose to implement the course at UT MD Anderson Cancer Center www.mdanderson.org.
The course is designed to teach biomedical researchers at UT System institutions how to start new companies and transfer their life-science discoveries more quickly into the clinic. The course is going to replicate NSF’s I-Corps www.nsf.gov/news/special_reports/i-corps program but the course will emphasize biomedical and life science technologies.
“This is a technology transfer initiative where entrepreneurship meets medicine,” said Will Rosellini, Principal Investigator for the project and Director for Commercialization for the Texas Biomedical Device Center www.utdallas.edu/txbdc.